Position in UTHR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,128,091
+$1,079,044 QoQ
Shares Held
8,648
+4.1% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $48,125,230 across 32 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
80,566 | $9,523,706 | |
| 2 | VTRS |
Viatris Inc
|
385,999 | $5,214,846 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
8,648 | $5,128,091 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
224,015 | $4,148,757 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
121,502 | $2,907,542 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
20,245 | $2,667,076 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
87,216 | $2,626,945 | |
| 8 | HLN |
Haleon plc
|
247,741 | $2,479,887 |
All Filings in UTHR
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,128,091 | 8,648 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,049,047 | 8,310 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,920,636 | 6,967 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,277,823 | 7,927 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,473,558 | 8,024 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,075,000 | 8,715 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,957,104 | 8,252 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,964,497 | 6,167 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $1,303,431 | 5,674 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $584,687 | 2,659 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $556,091 | 2,462 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $497,129 | 2,252 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $438,289 | 1,957 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $542,553 | 1,951 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $242,671 | 1,159 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $225,271 | 956 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||